UPDATED Apr 29, 2024
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
GTHX | US$3.77 | -10.0% | 26.9% | US$194.6m | US$8.50 | PS2.4x | E55.1% | n/a | Pharmaceuticals & Biotech | ||
ACTD | US$7.79 | -24.2% | -21.2% | US$303.0m | US$17.00 | PE-25.3x | E85.2% | n/a | Diversified Financials | ||
AZ | US$0.41 | -10.1% | -68.6% | US$21.6m | US$18.00 | PS1.8x | E75.4% | n/a | Capital Goods | ||
LICY | US$0.66 | -8.0% | -85.1% | US$125.1m | n/a | PS6.4x | E60.1% | n/a | Commercial Services | ||
SONM | US$0.53 | 10.4% | -47.3% | US$22.0m | US$2.00 | PB1x | E139.9% | n/a | Tech | ||
ZVRA | US$4.58 | 0% | -7.3% | US$190.4m | US$19.00 | PS7x | E63.6% | n/a | Pharmaceuticals & Biotech | ||
ZYNE | US$1.30 | 4.0% | 96.1% | US$65.6m | US$1.26 | PB2.3x | E67.2% | n/a | Pharmaceuticals & Biotech | ||
CKPT | US$1.39 | -3.1% | -54.3% | US$51.2m | US$17.25 | PS481.6x | E88.1% | n/a | Pharmaceuticals & Biotech | ||
IREN | US$4.34 | -22.2% | 11.3% | US$661.7m | US$11.00 | PS5x | E110.2% | n/a | Software | ||
ATNM | US$7.70 | 10.6% | -14.7% | US$219.8m | US$25.47 | PS2831.3x | E75.7% | n/a | Pharmaceuticals & Biotech | ||
AQMS | US$0.47 | -9.5% | -54.5% | US$56.6m | US$3.00 | PS2123.2x | E63.4% | n/a | Commercial Services | ||
OCUP | US$1.59 | 2.9% | -71.3% | US$40.9m | US$19.50 | PS2.1x | E9.5% | n/a | Pharmaceuticals & Biotech | ||
PGEN | US$1.32 | -5.7% | 16.8% | US$348.5m | US$9.00 | PS52.8x | E55.5% | n/a | Pharmaceuticals & Biotech | ||
MVST | US$0.39 | -14.0% | -61.8% | US$131.4m | US$4.50 | PB0.2x | E44.4% | n/a | Capital Goods | ||
XELB | US$0.75 | 11.1% | 27.4% | US$17.7m | US$3.00 | PB0.4x | E114.9% | n/a | Retail | ||
SCPH | US$4.47 | -3.0% | -57.8% | US$165.1m | US$19.50 | PS11.9x | E59.8% | n/a | Pharmaceuticals & Biotech | ||
AMPG | US$2.29 | -3.8% | -27.1% | US$22.5m | US$9.00 | PS1.4x | E107.0% | n/a | Tech | ||
PESI | US$11.45 | -1.6% | 36.1% | US$160.1m | US$19.00 | PE170.5x | E133.4% | n/a | Commercial Services | ||
PTGX | US$25.56 | -3.9% | 8.5% | US$1.5b | US$43.00 | PS25x | E50.0% | n/a | Pharmaceuticals & Biotech | ||
APLT | US$4.31 | -2.3% | 139.4% | US$489.0m | US$11.60 | PS49.3x | E81.9% | n/a | Pharmaceuticals & Biotech | ||
DTST | US$4.84 | 2.5% | 176.6% | US$34.5m | US$9.00 | PE87.8x | E65.4% | n/a | Software | ||
FTCI | US$0.45 | 14.2% | -83.0% | US$54.0m | n/a | PB0.9x | E63.1% | n/a | Capital Goods | ||
VRCA | US$7.15 | 5.3% | 10.2% | US$291.4m | US$13.60 | PS59.2x | E61.6% | n/a | Pharmaceuticals & Biotech | ||
LUMN | US$1.19 | -12.5% | -49.1% | US$1.2b | US$1.67 | PB2.9x | E144.7% | 0% | Telecom |